Money Talks: Why weight-loss drugs will reshape the world

Money Talks: Why weight-loss drugs will reshape the world

More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that can help people shed up to a fifth of their body weight. But these drugs promise to do more than boost drug companies’ profits. How will they reshape the economy?


Hosts: Alice Fulwood, Mike Bird and Tom Lee-Devlin. Guests: The Economist’s Georgia Banjo; pharmaceuticals analyst Michael Nedelcovych; and John Cawley, a professor of public policy and economics at Cornell University.


Subscribers to Economist Podcasts+ can listen to our January 2023 episode on the economics of thinness.


Sign up for our new weekly newsletter dissecting the big themes in markets, business and the economy at www.economist.com/moneytalks


Listen to what matters most, from global politics and business to science and technology—subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.

Hosted on Acast. See acast.com/privacy for more information.

Episoder(1955)

Oil rise: Trump gets the jitters

Oil rise: Trump gets the jitters

After oil prices climbed to nearly $120 a barrel yesterday, Donald Trump signalled a possible abrupt end to the conflict in Iran. Markets calmed, but the course of the war remains unclear. Why China’s...

10 Mar 23min

Follow the leader: Iran picks the son

Follow the leader: Iran picks the son

After Iran appoints a new supreme leader, what does the choice tell us about the resilience of the regime and how the war will progress? Scientific research in America has taken a battering in Donald ...

9 Mar 26min

The third Gulf war: one week on

The third Gulf war: one week on

After a momentous week, our editors reflect on how uncertainty about the goals of the war in Iran will affect its course. Iran’s retaliation has been fierce and wide ranging. How long can Gulf stocks ...

6 Mar 29min

Spars and strikes: Who backs Iran war?

Spars and strikes: Who backs Iran war?

As America continues to batter Iran, what are the domestic implications of the war for Donald Trump? The widening conflict has prompted some European countries to deploy defensive forces. France has a...

5 Mar 21min

Crude awakening: Iran oil shock

Crude awakening: Iran oil shock

As America and Israel continue to bombard Iran, much of Iran’s retaliation is directed against energy infrastructure. With tankers blocked and oil prices rising, our correspondent discusses the impact...

4 Mar 21min

Escalation: Middle East war widens

Escalation: Middle East war widens

The war in Iran has entered its fourth day with further American and Israeli strikes, and Iranian retaliation across the region. Now Israel’s prime minister Binyamin Netanyahu has launched a ground of...

3 Mar 24min

Trailer: Money Talks

Trailer: Money Talks

Join The Economist’s Mike Bird, Alice Fulwood and Ethan Wu for award-winning reporting and discussion on the stories that move markets. They speak to top bosses, investors and analysts around the worl...

2 Mar 52s

War with Iran: Middle East in flames

War with Iran: Middle East in flames

This weekend, America and Israel launched long-anticipated attacks on Iran, killing Ali Khamenei, the country’s supreme leader. Our correspondents analyse what his death means for the country and the ...

2 Mar 29min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
aftenpodden-usa
popradet
stopp-verden
lydartikler-fra-aftenposten
i-retten
rss-gukild-johaug
fotballpodden-2
det-store-bildet
dine-penger-pengeradet
nokon-ma-ga
rss-ness
hanna-de-heldige
aftenbla-bla
bt-dokumentar-2
e24-podden
frokostshowet-pa-p5
rss-dannet-uten-piano